Houseviews: Trading tips on 4 buzzing stocks

Wed, Feb 06, 2013 at 09:05

| Source: CNBC-TV18
Share   .   Email   .   Print      

Sun Pharma

Brokerage: Credit Suisse

Rating: Overweight

Target: Rs 840

Rationale: The doxil opportunity is still under-appreciated by the market, as it's likely to remain a low competition product and now becomes part of the base business.

Explore Moneycontrol

Copyright © Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of is prohibited.